Senior Health Channel
Topics & Medications
Related Channels

Rivastigmine Dosing

For those who are starting Alzheimer's or Parkinson's treatment with rivastigmine, dosing typically starts low and is increased gradually. The usual starting dose is 1.5 mg, taken twice a day. Your healthcare provider will most likely increase your rivastigmine dose after two to four weeks and continue to do so until an effective and safe dosage is reached.

An Introduction to Rivastigmine Dosing

The dose of rivastigmine tartrate (Exelon®) that your healthcare provider recommends will vary, depending on a number of factors, including:
  • How you respond to rivastigmine
  • Other medications you may take
  • Other medical conditions you may have.
As is always the case, do not adjust your dose unless your healthcare provider specifically instructs you to do so. This article refers to the oral forms of rivastigmine (capsules and oral solution). The drug also comes in patch form (see Rivastigmine Patch Dosing).

Rivastigmine Dosing for Alzheimer's Dementia

The starting dose of rivastigmine for Alzheimer's treatment is 1.5 mg twice daily. After two weeks, your healthcare provider may increase the dose to 3 mg twice daily. If necessary, your healthcare provider may further increase your dose to 4.5 mg twice daily after another two weeks. Finally, after another two weeks, if necessary (and if you tolerate rivastigmine well), your healthcare provider may increase your dose up to the maximum recommended amount: 6 mg twice daily.
Let your healthcare provider know if you develop bothersome or severe side effects of rivastigmine, such as severe nausea or vomiting. He or she may recommend stopping the drug for a short while and then restarting at the same or lower dose. If, at any time, you stop taking rivastigmine for an extended period, you must start over at the beginning dose and increase it slowly as before.
5 Questions to Ask Your Doctor About ED

Rivastigmine Tartrate Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.